Clinical Trials Directory

Trials / Conditions / Unresectable Thyroid Gland Carcinoma

Unresectable Thyroid Gland Carcinoma

7 registered clinical trials studyying Unresectable Thyroid Gland Carcinoma — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingRestor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
NCT05668962
Massachusetts General HospitalPhase 2
Active Not RecruitingLenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Met
NCT04171622
M.D. Anderson Cancer CenterPhase 2
CompletedLenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)
NCT02973997
Academic and Community Cancer Research UnitedPhase 2
Active Not RecruitingAtezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer
NCT03181100
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingDabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery
NCT01947023
National Cancer Institute (NCI)Phase 1
CompletedCediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer
NCT01208051
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedSunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be R
NCT00381641
National Cancer Institute (NCI)Phase 2